×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Program Committee
-
Rei Maeda Consultant
Independent Consultant for Drug PV, Japan -
Fumiyo Aoki Team Manager, Pharmacovigilance
AbbVie GK, Japan -
Hiroya Asou, MD, PhD, MBA Senior Medical Advisor, Global Patient Safety Japan
Eli Lilly Japan K.K., Japan -
Kasumi Daidoji, PhD, RPh Associate Director, Clinical Planning & Development Dept., Medical Headquarters
Eisai Company, Ltd., Japan -
Kazuhiko Ishida, MSc, RPh Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Kou Miyakawa Director
Takeda Pharmaceutical Company Limited, Japan -
Hiroyuki Murakami Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Mitsuo Saito, PhD Technical Advisor
Institute For Health Vigilance, Japan -
Junko Sato, PhD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Tomoko Yamada Director, Safety risk management, Pharmacovigilance
MSD K.K., Japan
Have an account?